...
首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents
【24h】

Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents

机译:基于triaza大环骨架和1-羟基-2(H)-吡啶-2-一配位基团的新型铁(III)螯合剂的合成及其作为抗菌剂的评价

获取原文
获取原文并翻译 | 示例
           

摘要

Several novel chelators based on 1-hydroxy-2(1H)-pyridinone coordinating groups decorating a triaza macrocyclic backbone scaffold were synthesised as potential powerful Fe3+ chelators capable of competing with bacterial siderophores. In particular, a novel chloromethyl derivative of 1-hydroxy-2(1H)-pyridinone exploiting a novel protective group for this family of coordinating groups was developed. These are the first examples of hexadentate chelators based on 1-hydroxy-2(1H)-pyridinone to be shown to have a biostatic activity against a range of pathogenic bacteria. Their efficacy as biostatic agents was assessed revealing that minor variations in the structure of the chelator can affect efficacy profoundly. The minimal inhibitory concentrations of our best tested novel chelators approach or are comparable to those for 1,4,7-tris(3-hydroxy-6-methyl-2-pyridylmethyl)-1,4,7-triazacyclononane, the best Fe3+ chelator known to date. The retarding effect these chelators have on microbial growth suggests that they could have a potential application as a co-active alongside antibiotics in the fight against infections. (C) 2016 The Authors. Published by Elsevier Inc.
机译:合成了几种新型的基于1-羟基-2(1H)-吡啶酮配位基团的新颖螯合剂,它们装饰着Triaza大环骨架骨架,可以作为潜在的功能强大的Fe3 +螯合剂,能够与细菌铁载体竞争。特别地,开发了一种新的1-羟基-2(1H)-吡啶酮的氯甲基衍生物,其为该配位基团家族开发了新的保护基。这些是基于1-羟基-2(1H)-吡啶酮的六齿螯合剂的第一个例子,被证明对一系列病原菌具有生物活性。评估了它们作为生物抑制剂的功效,揭示了螯合剂结构的微小变化会深刻影响功效。我们测试最好的新型螯合剂的最低抑菌浓度接近或与最佳Fe3 +螯合剂1,4,7-三(3-羟基-6-甲基-2-吡啶基甲基)-1,4,7-三氮杂环壬烷相当迄今已知。这些螯合剂对微生物生长的阻滞作用表明,它们可以作为抗菌素与抗生素一起作为潜在的抗感染药物。 (C)2016作者。由Elsevier Inc.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号